We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Microscopic image of a group of bacteria cells

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

News

NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines.

Robert Hureau Joins PPD

Company appoints Robert Hureau as executive vice president and chief financial officer.

Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub

Renowned neurologist to focus on accelerating the Company’s discovery and development of ALS therapies.

Merck Millipore Expands Biomanufacturing Sciences and Training Center in Japan

Facility expansion and relocation of existing operations from Yokohama, Kanagawa Prefecture to Tokyo.

Roche and InterMune Reach Definitive Merger Agreement

Roche to acquire InterMune for US$ 74.00 per share.

Bowel Disease Gene Discovery

Genetic changes that occur in patients with the bowel condition Crohn’s disease could hold clues to fighting the illness.

MRC Technology Negotiates License with Bio-Techne for MRC’s GOPAL Protein Synthesis Technology

Technology enables production of ubiquitin reagents and other proteins for use in drug discovery.

Cancer-Fighting Drugs Might Also Stop Malaria Early

A number of compounds have been identified which could be used to fight malaria.

Pfizer, Merck to Evaluate Novel Anti-Cancer Combination Regimen

This multi-center, open-label clinical study will be conducted by Pfizer and is expected to begin in 2015.

Exploring Innovations in SPR & Combination Screening

Genedata customers will discuss innovations in high content imaging, high throughput screening, compound combination screening, and other related topics at User Group Meetings.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter